170 related articles for article (PubMed ID: 28090249)
1. Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review.
Alkema M; Spitzer E; Soliman OI; Loewe C
J Cardiovasc Ultrasound; 2016 Dec; 24(4):257-267. PubMed ID: 28090249
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis.
Armstrong AC; Gjesdal O; Almeida A; Nacif M; Wu C; Bluemke DA; Brumback L; Lima JA
Echocardiography; 2014; 31(1):12-20. PubMed ID: 23930739
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
Jakubovic BD; Wald R; Goldstein MB; Leong-Poi H; Yuen DA; Perl J; Lima JA; Liu JJ; Kirpalani A; Dacouris N; Wald R; Connelly KA; Yan AT
Can J Cardiol; 2013 Mar; 29(3):384-90. PubMed ID: 23103220
[TBL] [Abstract][Full Text] [Related]
4. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography.
Barbieri A; Bursi F; Mantovani F; Valenti C; Quaglia M; Berti E; Marino M; Modena MG
Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):109-17. PubMed ID: 21979990
[TBL] [Abstract][Full Text] [Related]
6. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
Seo HY; Lee SP; Park JB; Lee JM; Park EA; Chang SA; Kim HK; Park SJ; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
[TBL] [Abstract][Full Text] [Related]
7. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Left Ventricular Hypertrophy in Obese Children Varies Depending on the Method Utilized to Determine Left Ventricular Mass.
Mahgerefteh J; Linder J; Silver EJ; Hazin P; Ceresnak S; Hsu D; Lopez L
Pediatr Cardiol; 2016 Aug; 37(6):993-1002. PubMed ID: 27033247
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: a critical appraisal.
Rautaharju PM; Soliman EZ
J Electrocardiol; 2014; 47(5):649-54. PubMed ID: 25012077
[TBL] [Abstract][Full Text] [Related]
10. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy.
Szwejkowski BR; Gandy SJ; Rekhraj S; Houston JG; Lang CC; Morris AD; George J; Struthers AD
J Am Coll Cardiol; 2013 Dec; 62(24):2284-93. PubMed ID: 23994420
[TBL] [Abstract][Full Text] [Related]
11. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
Huang BT; Peng Y; Liu W; Zhang C; Huang FY; Wang PJ; Zuo ZL; Liao YB; Chai H; Li Q; Zhao ZG; Luo XL; Ren X; Huang KS; Meng QT; Chen C; Huang DJ; Chen M
Eur J Clin Invest; 2014 Oct; 44(10):893-901. PubMed ID: 25104141
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular mass and atrial volume determined by cine magnetic resonance imaging in essential hypertension.
Mineoi K; Shigematsu Y; Ochi T; Hiwada K
Am J Hypertens; 2000 Oct; 13(10):1103-9. PubMed ID: 11041165
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
[TBL] [Abstract][Full Text] [Related]
14. Effect of Obesity on Left Ventricular Mass: Results from 320 Multi-Slices Computed Tomography.
Jongjirasiri S; Waeosak P; Laothamatas J; Sritara C; Saengruang-Orn S
J Med Assoc Thai; 2017 Feb; 100(2):219-29. PubMed ID: 29916642
[TBL] [Abstract][Full Text] [Related]
15. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy.
Mureddu GF; Pasanisi F; Palmieri V; Celentano A; Contaldo F; de Simone G
J Hypertens; 2001 Jun; 19(6):1113-9. PubMed ID: 11403361
[TBL] [Abstract][Full Text] [Related]
16. Clinical Value of Complex Echocardiographic Left Ventricular Hypertrophy Classification Based on Concentricity, Mass, and Volume Quantification.
Barbieri A; Albini A; Maisano A; De Mitri G; Camaioni G; Bonini N; Mantovani F; Boriani G
Front Cardiovasc Med; 2021; 8():667984. PubMed ID: 33987213
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass.
Vitale G; Galderisi M; Pivonello R; Spinelli L; Ciccarelli A; de Divitiis O; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2004 Mar; 60(3):343-9. PubMed ID: 15009000
[TBL] [Abstract][Full Text] [Related]
18. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.
de Simone G; Kizer JR; Chinali M; Roman MJ; Bella JN; Best LG; Lee ET; Devereux RB;
Am J Hypertens; 2005 Feb; 18(2 Pt 1):191-6. PubMed ID: 15752946
[TBL] [Abstract][Full Text] [Related]
19. Incidence of left ventricular hypertrophy in children with kidney disease: impact of method of indexation of left ventricular mass.
Simpson JM; Savis A; Rawlins D; Qureshi S; Sinha MD
Eur J Echocardiogr; 2010 Apr; 11(3):271-7. PubMed ID: 20015849
[TBL] [Abstract][Full Text] [Related]
20. Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction.
Stiermaier T; Pöss J; Eitel C; de Waha S; Fuernau G; Desch S; Thiele H; Eitel I
Clin Res Cardiol; 2018 Nov; 107(11):1013-1020. PubMed ID: 29766285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
